Diversity Supplement Grant

Overview

Dedicated to Lupus Research

The Lupus Research Alliance (LRA) is the largest private funder of lupus research worldwide. The organization aims to transform lupus treatment while advancing towards a cure by funding cutting-edge, innovative research and fostering diverse scientific talent. Addressing the challenges of lupus requires a talented and tenacious workforce capable of decoding the inherent complexity of the disease and devising innovative medicines. To harness the collective power of diverse minds and address the underrepresentation of specific groups in lupus research, the LRA has developed the Diversity in Lupus Research (DLR) Program to promote an outstanding diverse scientific pool of lupus research professionals.

Diversity Supplement.

The LRA Administrative Supplement to Promote Diversity in Lupus Research (“Diversity Supplement”) provides up to $30,000 for up to two years to promising trainees working with LRA-funded researchers or lupus investigators supported by the National Institutes of Health (NIH), Department of Defense (DOD), or equivalent grants in good standing.

Evaluation Criteria

The following criteria will be used to evaluate applications:

* PI’s commitment to mentoring and research training of URMs.
* Feasibility and quality of research plan for trainee and alignment with goals of
* parent grant.
* Evidence that the proposed experience will expand and foster the research
* capabilities, knowledge, and skills of the trainee and that a robust mentoring plan
* is in place.
* Level of trainee’s interest and commitment to a career in biomedical/lupus
* research.
* Trainee’s qualifications, including record of academic achievement, prior research
* experience, and assessment by the referee.

Eligibility

_You can learn more about this opportunity by visiting the funder's website._

* A principal investigator (PI) or “sponsor” must have an active LRA grant or currently hold an NIH, DOD, or equivalent grant in good standing that addresses major challenges in lupus research, including genetic causes of lupus and disease mechanisms, novel targets and pathways, or novel treatment approaches and technologies. 
* There must be at least one year of grant funding remaining at the time of application to be eligible to apply.
* The principal investigator should be committed to the goal of advancing ethnic and racial equity in lupus research by providing mentored research experiences for eligible trainees. 
* There is no citizenship requirement; however, the proposed research must be performed in a US- or Canada-based institution.

Ineligibility

* Funds may not be used for tuition, personal computers, or major laboratory equipment. 
* Indirect costs are not allowed.